Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of venetoclax based salvage chemotherapy followed by "Minimal Residual Disease driven"-venetoclax maintenance therapy post-allotransplant in a young patient with high risk primary refractory acute myeloid leukemia.
Todisco E, Gigli F, Sammassimo S, Camisaschi C, Mancuso P, Ronchini C, Ramadan S, Bertolini F, Pastano R, Tarella C. Todisco E, et al. Among authors: tarella c. Leuk Lymphoma. 2020 Sep;61(9):2277-2279. doi: 10.1080/10428194.2020.1759049. Epub 2020 May 2. Leuk Lymphoma. 2020. PMID: 32363964 No abstract available.
A three-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma.
Derenzini E, Mazzara S, Melle F, Motta G, Fabbri M, Bruna R, Agostinelli C, Cesano A, Corsini CA, Chen N, Righi S, Sabattini E, Chiappella A, Calleri A, Fiori S, Tabanelli V, Cabras A, Pruneri G, Vitolo U, Gianni AM, Rambaldi A, Corradini P, Zinzani PL, Tarella C, Pileri S. Derenzini E, et al. Among authors: tarella c. Haematologica. 2021 Sep 1;106(9):2405-2416. doi: 10.3324/haematol.2019.236455. Haematologica. 2021. PMID: 32817282 Free PMC article.
Clinical presentation, diagnosis and management of therapy-related hematological disorders in women with epithelial ovarian cancer treated with chemotherapy and poly-ADP-ribose polymerase inhibitors: A single-center experience.
Todisco E, Gigli F, Mantiero M, Sammassimo S, Pastano R, Ronchini C, Parma G, Lapresa MT, Iori AP, Bertolini F, Corsini C, Gregato G, Poletti C, Colombo N, Tarella C. Todisco E, et al. Among authors: tarella c. Int J Cancer. 2021 Jan 1;148(1):170-177. doi: 10.1002/ijc.33269. Epub 2020 Sep 16. Int J Cancer. 2021. PMID: 32856727 Free article.
Prognostic Impact of Baseline Immunologic Profile in Aggressive B-cell non-Hodgkin's Lymphomas.
Ramadan S, Ceparano G, Cignetti A, Sammassimo S, Bagnardi V, Pagan E, Gottardi D, Fiori S, Passerini R, Radice T, Saglio G, Tarella C. Ramadan S, et al. Among authors: tarella c. Mediterr J Hematol Infect Dis. 2021 Mar 1;13(1):e2021018. doi: 10.4084/MJHID.2021.018. eCollection 2021. Mediterr J Hematol Infect Dis. 2021. PMID: 33747399 Free PMC article.
Pre-existing immune checkpoints activation predicts relapse after allogeneic stem cell transplantation in lymphoma.
Derenzini E, Tabanelli V, Sammassimo S, Mazzara S, Motta G, Melle F, Vanazzi A, Calleri A, Fiori S, Finazzi MC, Barbanti MC, Ramadan S, Gandini S, Pastano R, Rambaldi A, Pileri S, Tarella C. Derenzini E, et al. Among authors: tarella c. Bone Marrow Transplant. 2021 Sep;56(9):2280-2283. doi: 10.1038/s41409-021-01320-y. Epub 2021 May 7. Bone Marrow Transplant. 2021. PMID: 33963303 No abstract available.
Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma.
Rossi A, Orecchioni S, Falvo P, Tabanelli V, Baiardi E, Agostinelli C, Melle F, Motta G, Calleri A, Fiori S, Corsini C, Casadei B, Mazzara S, Vitolo U, Bertolini F, Zinzani PL, Alcalay M, Pelicci PG, Pileri S, Tarella C, Derenzini E. Rossi A, et al. Among authors: tarella c. Leukemia. 2022 Jan;36(1):197-209. doi: 10.1038/s41375-021-01347-6. Epub 2021 Jul 24. Leukemia. 2022. PMID: 34304248 Free PMC article. Clinical Trial.
194 results